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Interference of fetal hemoglobin and labile glycosylated hemoglobin with measurements of glycosylated hemoglobin. Clin C/tern 29, This rapid, accurate "high-performance" liquid-chromatographic procedure is intended for measuring indomethacin in serum from neonates who are receiving indomethacin for symptomatic patent ductus arteriosus. Indomethacin and an internal standard (flufenamic acid) are extracted from serum or plasma with chloroform or diethyl ether at pH 5.0. For the chromatography we used a Waters' Radial Compression Separation System (Radial-NOVA PAK C18 reversed-phase column) and a mobile phase of methanol/sodium acetate buffer (10 mmol/L, pH 3.6), 70/30 by vol. The column effluent is monitored at 254 nm. Both indomethacin and flufenamic acid are eluted within 7 mm. Indomethacin can be detected in concentrations as low as 50 &g/L, in 100-L
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samples.
Response vanes linearly with indomethacin concentration to at least 2 mg/L. Analytical recovery is 75%; relative recovery is 100%. Precision is excellent. Using this method, we were able to improve the success rate for pharmacological management of symptomatic patent ductus arteriosus, especially in neonates with fast clearance rates for the drug. They concluded that successful use of indomethacin was associated with a concentration of the drug exceeding 250 g per liter of plasma 24 h after its infusion. However, they also found a 20-fold variation in these values. Such variation and the relation between concentrations of the drug in plasma and ductus constriction make important the rapid measurement of indomethacin during the 6 to 24 h after the drug is first administered, so that the second dose can be correctly scheduled.
The various methods for determination of indomethacin include spectrofluorometry (4, 5), gas-liquid chromatography (6, 7), radioimmunoassay (RIA) (8, 9), and "highperformance" liquid chromatography (HPLC) (10-16). Spectrofluorometry is nonspecific, time-consuming, and requires a large volume of sample. Gas-liquid chromatography is more specific but is time-consuming and requires derivatization. RIA, although highly sensitive, is impractical for urgent determinations.
Several reported HPLC methods either lack the necessary sensitivity or are subject to endogenous interference. Recently, Mehta and Calvert (17) reported a,n improved HPLC procedure for monitoring indomethacm in neonates, involving a 10-zm Radial-PAR C18 reversed-phase column. However, this method, a modification of the Skellern and Sable procedure (10), is subject to endogenous interferences, especially for plasma samples.
In 1981, we developed a liquid-chromatographic method for rapidly determining indomethacin in neonates. 3 We have now tested the method over a two-year period and modified it to improve its accuracy and precision. Here, we report in detail this improved procedure.
Materials and Methods
Apparatus.
We compressedC18reversed-phase column (NovA PAK Recovery. To assess analytical recovery, we compared the peak height measured for a drug-added serum sample (after extraction) with that of an aqueous solution containing the same concentration of indomethacin (direct injection without extraction). Relative recovery was calculated by comparing the quantities measured for drug-added serum with the actual quantities added. To assess interference, we analyzed serum from more than 30 patients who were not receiving indomethacin, but some of whom were being treated with other drugs. Figure 1 shows the relation between pH and the extraction of indomethacin. Analytical recovery was greatest at pH 5, which is consistent with the results of Helleberg (6) except that we noted no marked decrease in recovery when the pH was either higher or lower than 5.0. In our hands, with use of the phosphate buffer the recovery at pH 4.0 was 96% of that at pH 5.0. Figure 2 depicts the separation of the indomethacin metabolites desbenzoylindomethacin and O-desmethylindomethacin from indomethacin and internal standard. Elution of these metabolites overlaps with that of endogenous contaminants in serum or plasma, so their quantification may not be feasible.
Results
Typical chromatograms of serum and plasma specimens are shown in Figure 3 . Note the extraneous peaks between indomethacin and internal standard in the chromatogram of plasma specimens. The major peak does not appear in the chromatogram of serum specimens. We do not know the nature of this peak, but it occurs only in plasma samples. The pH of the mobile phase is very important in resolving 10 12 this extraneous peak from either indomethacin or flufenamic acid. If the pH of the mobile phase exceeds 3.6, the retention times of indomethacin and internal standard shorten but the peak for the endogenous plasma component
Rst.nUon'Tkns (n Fig. 3 . Chromatogramsof extract of (left) plasma containing600 of indomethacin (INDO) and 2.5 mg of flufenan,ic acid (FA) per liter, and (Ngh) patient'sserum containing 650 ig of indomethacinand 2.5mg of flulenamic acid per liter moves toward the peak for indomethacin and may overlap it. If the pH of the mobile phase is less than 3.6, the plasma component may elute with flufenamic acid. Therefore, a pH of 3.6 ± 0.05 is critical to optimal resolution.
Chromatographic separation and recovery are the same, whether chloroform or diethyl ether is used as an extraction solvent. However, chloroform tends to produce an emulsion with serum or plasma and on withdrawing the chloroform layer from the bottom of test tube one can easily contaminate the aspirated fluid with emulsion. Therefore, ether may be advantageous in this sense. The volume ratio of methanol to acetate buffer may need to be varied slightly, depending on the column used. In general, we found the 7:3 ratio optimal.
The between-day precision of the method (n = 60) was assessed by repeated analyses of serum specimens containing various concentrations of indomethacin. The CVs were 7.2% and 4.8%, respectively, for concentrations of 243 and 491 p.g per liter of serum. Analytical recovery for the procedure was 75%; relative recovery was 100%. The method can be used to detect indomethacin in concentrations as low as 50 p.g/L when a 100-p.L sample is used. The linearity of the peak height response/drug concentration relation extends to at least 2 mg/L.
When we analyzed sera from more than 30 patients who were not receiving indomethacin, we found no peaks with retention times similar to those of indomethacin or internal standard. In addition, commonly used drugs such as phenobarbital, phenytoin, ethosuximide, carbamazepine, primidone, acetominophen, salicylate, theophylline, caffeine, procainamide, N-acetylprocamnamide, quinidine, and propranolol do not interfere with the analysis.
Discussion
Treatment of symptomatic PDA with indomethacin has become a popular alternative to surgical ligation since 1976, although its effectiveness remains controversial. Indomethacm inhibits synthesis of prostaglandin E in many neonates, but we do not yet know the price of this elegant pharmacological maneuver, i.e., the drug's effect on intraventricular hemorrhage, necrotizing enterocolitis, or the many other possible complications involving the systems affected by prostaglandins. Nor do we know the effects of the complete or partial inhibition of the synthesis of all prostaglandins in the first few postnatal days. Ideally, development of a drug to inhibit specifically the synthesis of prostaglandin E2, the one presumed to be responsible for dilating the ductus (18,  19) , may reduce the risks of pharmacological management of PDA. Until then, the rapid, accurate assay of indomethacm will be very useful for establishing an optimal dosage schedule for the permanent closure of ductus without adverse side effects.
The chromatographic conditions we report give excellent resolution, including resolution of endogenous components from indomethacin and the internal standard. Turnaround time for a result is only 7 mm, and we can analyze six to eight samples per hour. The mobile phase can be recycled as described elsewhere (20). After each day's use the NOVA-PAK column can be stored in a screw-capped tube containing the same mobile phase. This shortens the equilibration time for the next use of the column and the column can be used for more than 300 injections.
During the last two years, we evaluated three Waters' "Radial PAK" reversed-phase columns and five regular stainless-steel C18 columns for this purpose. We found that the Radial PAK columns perform better than the other columns we tested and that, of the various Radial PAK columns, the NOVA-PAK C18reversed-phase columns give the best resolution, completely resolving a small contaminant peak from the peak for indomethacin. If the Radial PAK C18 5-p.m particle-size column is used, this peak appears as a "shoulder" and may be inappropriately integrated. Using peak-height ratios (indomethacinlinternal standard) as the method of calculation can improve the accuracy with this column. The 10-p.m Radial PAK C18column does not resolve this peak from indomethacin.
We now have used this method routinely for more than two years, during which the success rate of the pharmacological management of PDA in our neonatal population has increased quite drastically, especially in the case of those neonates who metabolize indomethacin unusually rapidly. The minimum effective concentration of indomethacin and how long it should be maintained for maximum success with minimal adverse effects are still under investigation.
